• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For April 4, 2024

    4/4/24 5:18:17 AM ET
    $ANGO
    $CAG
    $CLGN
    $CNFR
    Medical/Dental Instruments
    Health Care
    Packaged Foods
    Consumer Staples
    Get the next $ANGO alert in real time by email

    Companies Reporting Before The Bell

    • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.

    • Trinity Biotech (NASDAQ:TRIB) is projected to report quarterly earnings at $0.00 per share on revenue of $15.00 million.

    • AngioDynamics (NASDAQ:ANGO) is estimated to report quarterly loss at $0.13 per share on revenue of $75.73 million.

    • WisdomTree International LargeCap Dividend Fund (NYSE:DOL) is likely to report quarterly earnings at $1.06 per share on revenue of $1.61 billion.

    • Reliance Global Group (NASDAQ:RELI) is likely to report earnings for its fourth quarter.

    • Lamb Weston Hldgs (NYSE:LW) is estimated to report quarterly earnings at $1.45 per share on revenue of $1.65 billion.

    • Radius Recycling (NASDAQ:RDUS) is likely to report quarterly loss at $1.09 per share on revenue of $626.15 million.

    • Simply Good Foods (NASDAQ:SMPL) is likely to report quarterly earnings at $0.38 per share on revenue of $316.88 million.

    • CollPlant Biotechnologies (NASDAQ:CLGN) is estimated to report quarterly loss at $0.07 per share on revenue of $8.56 million.

    • RPM Intl (NYSE:RPM) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.52 billion.

    • Lindsay (NYSE:LNN) is estimated to report quarterly earnings at $1.55 per share on revenue of $172.06 million.

    Companies Reporting After The Bell

    • Conifer Holdings (NASDAQ:CNFR) is likely to report quarterly loss at $0.02 per share on revenue of $15.46 million.

    • Movano (NASDAQ:MOVE) is estimated to report earnings for its fourth quarter.

    • Kura Sushi USA (NASDAQ:KRUS) is projected to report quarterly loss at $0.03 per share on revenue of $56.64 million.

    • Genfit (NASDAQ:GNFT) is likely to report earnings for its Fiscal Year 2023.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ANGO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANGO
    $CAG
    $CLGN
    $CNFR

    CompanyDatePrice TargetRatingAnalyst
    RPM International Inc.
    $RPM
    1/9/2026$115.00Neutral → Overweight
    Analyst
    Lamb Weston Holdings Inc.
    $LW
    12/22/2025Outperform → Neutral
    BNP Paribas Exane
    RPM International Inc.
    $RPM
    12/9/2025$132.00Sector Perform → Outperform
    RBC Capital Mkts
    RPM International Inc.
    $RPM
    10/14/2025$129.00Neutral → Buy
    BofA Securities
    Lamb Weston Holdings Inc.
    $LW
    8/20/2025$57.00Neutral
    Analyst
    ConAgra Brands Inc.
    $CAG
    8/20/2025$20.00Neutral
    Analyst
    GENFIT S.A.
    $GNFT
    8/19/2025$9.00Buy
    H.C. Wainwright
    RPM International Inc.
    $RPM
    8/14/2025$128.00Underperform → Neutral
    BofA Securities
    More analyst ratings

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RPM Inc upgraded by Analyst with a new price target

    Analyst upgraded RPM Inc from Neutral to Overweight and set a new price target of $115.00

    1/9/26 8:33:00 AM ET
    $RPM
    Paints/Coatings
    Consumer Discretionary

    Lamb Weston downgraded by BNP Paribas Exane

    BNP Paribas Exane downgraded Lamb Weston from Outperform to Neutral

    12/22/25 11:24:00 AM ET
    $LW
    Packaged Foods
    Consumer Staples

    RPM Inc upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded RPM Inc from Sector Perform to Outperform and set a new price target of $132.00

    12/9/25 8:35:22 AM ET
    $RPM
    Paints/Coatings
    Consumer Discretionary

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Craps Jan Eli B bought $2,432,330 worth of shares (50,000 units at $48.65) and was granted 317,647 shares, increasing direct ownership by 147% to 617,647 units (SEC Form 4)

    4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:10:07 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    Chief Commercial Officer Clawson Michael L bought $100,000 worth of shares (5,000 units at $20.00), increasing direct ownership by 15% to 37,620 units (SEC Form 4)

    4 - Simply Good Foods Co (0001702744) (Issuer)

    11/19/25 6:37:24 PM ET
    $SMPL
    Packaged Foods
    Consumer Staples

    Chief Financial Officer Bealer Christopher J bought $199,019 worth of shares (9,946 units at $20.01), increasing direct ownership by 43% to 32,966 units (SEC Form 4)

    4 - Simply Good Foods Co (0001702744) (Issuer)

    11/10/25 9:01:45 AM ET
    $SMPL
    Packaged Foods
    Consumer Staples

    $ANGO
    $CAG
    $CLGN
    $CNFR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/21/22 4:37:57 AM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/23/21 5:39:20 PM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    FDA Tentative Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Tentative Approval' on 10/28/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    10/29/21 4:44:50 AM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation

    Approval Marks Final Regulatory Milestone Required to Enable Launch of Upstream Manufacturing Activities Under New Offshored & Outsourced Production Model Expected to Drive Gross Margin Expansion, Improve Working Capital Efficiency, and Enhance Long‑Term Scalability  Represents a Key Final Component of the Company's Comprehensive Transformation Plan DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has now received full regulatory approval for the commencement of upstream manufacturing activities for

    2/10/26 1:28:10 PM ET
    $TRIB
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026

    – Reinforces Trinity Biotech's growing position as a key player in diabetes care innovation – Senior commercial executives of Trinity Biotech are attending the World Health Expo from February 10-12, 2026 DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that its Premier Hb9210™ HbA1c Analyser with its recently launched next-generation Buffer A Plus column system has achieved the prestigious Gold Classification from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) for 202

    2/10/26 8:00:00 AM ET
    $TRIB
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Lamb Weston Announces Inducement Award Under NYSE Listing Rule 303A.08

    Lamb Weston Holdings, Inc. (NYSE:LW) announced today that on February 6, 2026, the company granted 317,647 restricted stock units and options covering an aggregate of 1,117,346 shares of the company's common stock (collectively, the "Inducement Awards") to Jan Craps. The company's Compensation and Human Capital Committee approved the grant of Inducement Awards, made under the Lamb Weston Holdings, Inc. 2026 Inducement Stock Plan, to Mr. Craps as a material inducement to Mr. Craps' hiring as Executive Chair on February 6, 2026. 300,000 restricted stock units of Mr. Craps' award were granted as a one-for-one match on Mr. Craps' personal investment in Lamb Weston shares. The restricted stock u

    2/6/26 5:48:00 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    $ANGO
    $CAG
    $CLGN
    $CNFR
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by AngioDynamics Inc.

    SCHEDULE 13G - ANGIODYNAMICS INC (0001275187) (Subject)

    2/10/26 4:44:09 PM ET
    $ANGO
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form S-1/A filed by Movano Inc.

    S-1/A - Movano Inc. (0001734750) (Filer)

    2/9/26 5:00:29 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SCHEDULE 13G filed by Kura Sushi USA Inc.

    SCHEDULE 13G - KURA SUSHI USA, INC. (0001772177) (Subject)

    2/6/26 5:21:21 PM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Craps Jan Eli B bought $2,432,330 worth of shares (50,000 units at $48.65) and was granted 317,647 shares, increasing direct ownership by 147% to 617,647 units (SEC Form 4)

    4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:10:07 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    New insider Craps Jan Eli B claimed ownership of 250,000 shares (SEC Form 3)

    3 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:09:13 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    CHIEF HUMAN RESOURCES OFFICER Younes Steven J was granted 13,680 shares, increasing direct ownership by 56% to 37,976 units (SEC Form 4)

    4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:08:23 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Leadership Updates

    Live Leadership Updates

    View All

    Kura Sushi USA Announces Election of Claudia Schaefer to the Company's Board of Directors

    IRVINE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company"), (NASDAQ:KRUS), a technology-enabled Japanese restaurant concept, today announced that Claudia Schaefer has been elected to serve as an independent member of the Board of Directors effective January 21, 2026. In conjunction with Ms. Schaefer's nomination, Kim Ellis did not stand for re-election as a director, also effective January 21, 2026. Hajime Uba, President, Chief Executive Officer and Chairman of Kura Sushi, stated, "We are thrilled to announce the election of Claudia to Kura Sushi USA's Board of Directors. Claudia's deep brand and marketing background makes her an excellent addit

    1/22/26 4:05:00 PM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    Manitowoc Board of Directors Appoints Mark B. Rourke and Randy A. Wood as New Directors

    The Manitowoc Company, Inc. (NYSE:MTW) (the "Company" or "Manitowoc"), a leading global manufacturer of cranes and lifting solutions, today announced that Mark B. Rourke and Randy A. Wood have been appointed to the Company's board of directors effective immediately. Mark Rourke is President and Chief Executive Officer of Schneider National (NYSE:SNDR), a leading transportation and logistics company in North America. Since joining Schneider in 1987, Mr. Rourke has served in a variety of roles with increasing responsibility, including Executive Vice President and Chief Operating Officer and President of Truckload Services. He became CEO in 2019, driving strategic acquisitions and expanding

    1/21/26 9:00:00 AM ET
    $LNN
    $MTW
    $SNDR
    Industrial Machinery/Components
    Industrials
    Construction/Ag Equipment/Trucks
    Trucking Freight/Courier Services

    Simply Good Foods Appoints Joe Scalzo as President and Chief Executive Officer

    DENVER, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ:SMPL) ("Simply Good Foods" or the "Company"), a leader in the Nutritional Snacking category, today announced the return and appointment of longtime former executive Joe Scalzo as President and Chief Executive Officer. Mr. Scalzo will oversee a new chapter at Simply Good Foods focused on reigniting growth and improving profitability across the business. Mr. Scalzo, who previously served as Chief Executive Officer of the Company until July 2023 and as Executive Vice Chairman until August 2024, succeeds Geoff Tanner, effective immediately. Mr. Scalzo will be appointed as a member of the Board of Directors on Janu

    1/20/26 8:00:00 AM ET
    $SMPL
    Packaged Foods
    Consumer Staples

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Trinity Biotech plc

    SC 13D/A - TRINITY BIOTECH PLC (0000888721) (Subject)

    11/14/24 5:26:28 PM ET
    $TRIB
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Reliance Global Group Inc.

    SC 13G/A - Reliance Global Group, Inc. (0001812727) (Subject)

    11/14/24 4:26:59 PM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form SC 13G filed by The Simply Good Foods Company

    SC 13G - Simply Good Foods Co (0001702744) (Subject)

    11/14/24 1:28:33 PM ET
    $SMPL
    Packaged Foods
    Consumer Staples

    $ANGO
    $CAG
    $CLGN
    $CNFR
    Financials

    Live finance-specific insights

    View All

    Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation

    Approval Marks Final Regulatory Milestone Required to Enable Launch of Upstream Manufacturing Activities Under New Offshored & Outsourced Production Model Expected to Drive Gross Margin Expansion, Improve Working Capital Efficiency, and Enhance Long‑Term Scalability  Represents a Key Final Component of the Company's Comprehensive Transformation Plan DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has now received full regulatory approval for the commencement of upstream manufacturing activities for

    2/10/26 1:28:10 PM ET
    $TRIB
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026

    – Reinforces Trinity Biotech's growing position as a key player in diabetes care innovation – Senior commercial executives of Trinity Biotech are attending the World Health Expo from February 10-12, 2026 DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that its Premier Hb9210™ HbA1c Analyser with its recently launched next-generation Buffer A Plus column system has achieved the prestigious Gold Classification from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) for 202

    2/10/26 8:00:00 AM ET
    $TRIB
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Presurance Holdings Rights Offering Begins

    TROY, Mich., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Presurance Holdings, Inc. (NASDAQ:PRHI) ("Presurance" or the "Company") today announced the commencement of its rights offering, previously detailed in the Company's Current Report on Form 8-K filed on January 28, 2026. Shareholders of record on February 6, 2026 are now being distributed a dividend of one non-transferable Subscription Right ("Subscription Right") for each share of common stock owned on the record date. Each Subscription Right, when exercised before the expiration date of 5:00 p.m. New York City time on February 24, 2026, entitles the holders to purchase 1.145 shares of Presurance common stock at a subscription price of $1.00

    2/6/26 5:07:01 PM ET
    $CNFR
    $PRHI
    Property-Casualty Insurers
    Finance